Tomás Takes Charge by Charlene Joy Talbot

Consistent results were seen in all prespecified subgroups of patients. Overall, 1222 (17%) of 7351 patients allocated to aspirin and 1299 (17%) of 7541 patients allocated to usual care died within 28 days (rate ratio 0♹6, 95% CI 0♸9–1♰4 p=0♳5). 7351 patients were randomly allocated (1:1) to receive aspirin and 7541 patients to receive usual care alone. Individuals wishing to request access should complete the form at and e-mail Nov 1, 2020, and March 21, 2021, 14 892 (66%) of 22 560 patients enrolled into the RECOVERY trial were eligible to be randomly allocated to aspirin. Data will be made available in line with the policy and procedures described at. The Steering Committee will have the right to review and comment on any draft manuscripts before publication. However, the Steering Committee will need to be satisfied that any proposed publication is of high quality, honours the commitments made to the study participants in the consent documentation and ethical approvals, and is compliant with relevant legal and regulatory requirements (eg, relating to data protection and privacy). Deidentified participant data will be made available to researchers registered with an appropriate institution within 3 months of publication. As described in the protocol, the trial Steering Committee will facilitate the use of the study data and approval will not be unreasonably withheld. The protocol, consent form, statistical analysis plan, definition and derivation of clinical characteristics and outcomes, training materials, regulatory documents, and other relevant study materials are available online at.

Tomás Takes Charge by Charlene Joy Talbot